Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantern Pharma Inc.

3.32
-0.1100-3.21%
Post-market: 3.13-0.1893-5.70%19:31 EDT
Volume:61.19K
Turnover:204.07K
Market Cap:35.81M
PE:-1.80
High:3.43
Open:3.28
Low:3.25
Close:3.43
Loading ...
Jan 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 08, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 06, 2021

Major Issues Report

8-K - Current report
Oct 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2020

Major Issues Report

8-K - Current report
Aug 21, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2020

Major Issues Report

8-K - Current report
Jun 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 19, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 17, 2020

Major Issues Report

8-K - Current report
Jun 08, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 08, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 08, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 02, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 22, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 19, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 19, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses